3,852 | 19 | 12 |
下载次数 | 被引频次 | 阅读次数 |
目的:通过网络药理学探究麻黄-苍术治疗新型冠状病毒肺炎(COVID-19)的作用靶点及信号通路,阐述其作用机制。方法:利用TCMSP、BATMAN-TCM数据库和相关文献筛选出麻黄-苍术的活性成分及靶标;通过GeneCards数据库筛选2019-nCoV的预测靶点;将两者靶点进行映射;利用Cytoscape3.7.2数据库构建活性成分-靶点网络图并筛选出核心靶点;再通过GOEAST、DAVID分别进行GO生物过程、KEGG通路富集分析。结果:根据筛选条件共获得麻黄-苍术活性成分32个,潜在作用靶点216个;与2019-nCoV共同靶点48个,关键靶点10个;获得1 303条GO生物过程,在细胞生物过程正调控、生物节律调节、细胞对刺激的反应等方面靶点富集较集中;56条KEGG信号通路,靶点在甲型流感、百日咳、肺结核、乙型肝炎等通路上富集较多。结论:麻黄-苍术通过多靶点、多通路起到抗病毒、抑菌退热、止咳化痰、调节免疫的作用,最终达到治疗COVID-19的效果。
Abstract:Objective: To explore the targets and signaling pathways of Ephedrae Herba-Atractylodis Rhizoma in the treatment of novel coronavirus pneumonia(COVID-19) by network pharmacology, to expound its mechanism.Methods: The TCMSP,BATMAN-TCM databases and related literatures were used to screen out the active components and targets of Ephedrae Herba-Atractylodis Rhizoma; The GeneCards database was used to screen the predicted targets of 2019-nCoV;Two targets were mapped; The Cytoscape3.7.2 database was used to construct the network diagram of active components-targets and screen out the core targets; The GO biological process, KEGG pathway enrichment analysis were carried out by GOEAST and DAVID,respectively.Results: According to the screening conditions, 32 active components of Ephedrae Herba-Atractylodis Rhizoma and 216 potential targets were obtained.48 common targets related with 2019-nCoV were obtained, 10 key targets and 1 303 GO biological processes were obtained.The targets were concentrated in the positive regulation of cellular biological processes, the regulation of biological rhythms and the response of cells to stimuli.56 KEGG signaling pathways were obtained and the targets were rich in influenza a, pertussis, tuberculosis, hepatitis b and other pathways.Conclusion: Ephedrae Herba-Atractylodis Rhizoma plays the roles of antivirus, bacteriostatic and antifebrile, cough and phlegm relieving, immune regulation through multiple targets and multiple pathways and finally achieves the effect of treating COVID-19.
[1] 疾病预防控制局.中华人民共和国国家卫生健康委员会公告:2020年第1号[EB/OL].(2020-01-20)[2020-01-20].http://www.nhc.gov.cn/jkj/s7916/202001/44a3b8245e8049d2837a4f27529cd386.shtml.
[2] 国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第六版修正版)的通知[EB/OL].(2020-01-20)[2020-01-20].http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm.
[3] 王怡菲,邱模炎,裴颢,等.中医药辨治新型冠状病毒肺炎的组方及用药规律探析[J].世界中医药,2020,15(3):344-347.
[4] 薛伯寿,姚魁武,薛燕星.“清肺排毒汤”快速有效治疗新型冠状病毒肺炎的中医理论分析[J].中医杂志,2020,61(6):461-462.
[5] 李杰,石金凤,聂欣,等.基于网络药理学的四物汤治疗原发性痛经的作用机制研究[J].中国中药杂志,2019,44(3):559-565.
[6] 仝小林,李修洋,赵林华,等.从“寒湿疫”角度探讨新型冠状病毒肺炎的中医药防治策略[J].中医杂志,2020,61(6):465-470,553.
[7] 李聪,胡强,张燕翔,等.槲皮素的药理学活性研究进展[J].湖北中医杂志,2018,40(6):63-66.
[8] WU SN,CHIANG HT,SHEN AY,et al.Differential effects of quercetin,a natural polyphenolic flavonoid,on L-Type calcium current in pituitary tumor(GH3)cells and neuronal NG108-15 cells[J].J Cell Physiol,2003,195(2):298-308.
[9] 万巧凤,吴莉,杨美玲,等.槲皮素对甲型H1N1流感病毒诱导的A549细胞凋亡效应酶Caspase-3的影响[J].中国中医药信息杂志,2011,18(10):42-44.
[10] 雷晓青,陈鳌,刘毅,等.山萘酚药理作用的研究进展[J].微量元素与健康研究,2017,34(2):61-62.
[11] 何丽娜,何素冰,杨军.木犀草素体外抗柯萨奇B3病毒的作用[J].中国现代应用药学,2000,17(5):362-365.
[12] 王倩,谢明杰.木犀草素对金黄色葡萄球菌的抑菌活性及其机制[J].微生物学报,2010,50(9):1180-1184.
[13] 李林林,龚国清,冯贻东,等.木犀草素对四氯化碳致大鼠肝纤维化的保护作用及其机制研究[J].中国生化药物杂志,2010,31(6):377-380.
[14] 邓东沅,顾立刚,刘晓婷,等.木犀草素体外对H1N1感染A549作用的研究[J].中医药导报,2017,23(3):11-14.
[15] 吴修华,刘妮,杨丽,等.黄芩素体内抗甲型流感病毒作用的研究[J].广州中医药大学学报,2009,26(2):157-159,200.
基本信息:
DOI:10.13863/j.issn1001-4454.2020.07.046
中图分类号:R285
引用信息:
[1]杨璐平,盖聪,周梦琪等.麻黄-苍术治疗新型冠状病毒肺炎机制的网络药理学探讨[J].中药材,2020,43(07):1779-1785.DOI:10.13863/j.issn1001-4454.2020.07.046.
基金信息:
北京中医药大学新冠肺炎防控应急专项(2020-JYB-YJ-006)